DPP4 and hepatocellular carcinoma: Therefore, inhibition of M1 polarization and/or alternative activation of M2 polarization of macrophages by DPP4 inhibitors may protect against exacerbation of inflammation and attenuate the progression to steatohepatitis and HCC.